STOCKHOLM With pressures to provide ever greater value for money spilling out of Europe and into the U.S., interest in leveraging open innovation to access fresh ideas at the earliest possible moment is gaining increasing traction in all quarters of the industry, delegates at BIO-Europe said Monday. Motivations for creating that value differ from player to player, but academic, corporate and financial players are finding common ground, they said.
Paris-based Sanofi SA already relies on its global centers of excellence to reach out to academia throughout the world. Soon it will extend its search by helping to create new incubators on both the east and west coasts of the U.S. to attract and mature early stage ideas into companies in which its investment arm can be active, said Sarah Holland, head of the company's European external science and partnering, "For us, the benefit will be that we see what comes through the incubators. We get to see the